Source: freePRnow

Press Release: Spring Bioscience : Spring Bioscience Develops Antibodies for IHC Use

Spring Bioscience is pleased to announce the company develops and manufactures antibodies, which are designed for use in immunohistochemistry, or IHC.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100